Results 1 to 10 of about 651,532 (328)

HIV treatment as prevention: models, data, and questions--towards evidence-based decision-making. [PDF]

open access: yesPLoS Medicine, 2012
Antiretroviral therapy (ART) for those infected with HIV can prevent onward transmission of infection, but biological efficacy alone is not enough to guide policy decisions about the role of ART in reducing HIV incidence.
HIV Modelling Consortium Treatment as Prevention Editorial Writing Group
doaj   +3 more sources

HIV Prevention

open access: yes
Abstract The HIV prevention field continues to expand and now encompasses a vast range of approaches and tools across biomedical, behavioral, social, and structural dimensions. Long-acting agents and innovative implementation approaches are being explored to increase not only the number of available options, but also accessibility and ...
Swinkels HM   +3 more
europepmc   +2 more sources

HIV Prevention [PDF]

open access: yes, 2021
Abstract Preexposure prophylaxis (PrEP) with daily tenofovir disoproxil fumarate/emtricitabine can reduce the risk of HIV infection by more than 90% for patients who are highly adherent. When considering PrEP, the first step is to determine the risk of HIV acquisition based on sexual risk behaviors during the past 6 months.
Saira R. Ajmal, Mary J. Kasten
  +5 more sources

The feasibility of modified HIV and antiretroviral drug testing using self-collected dried blood spots from men who have sex with men

open access: yesBMC Infectious Diseases, 2021
Background In the US, one in six men who have sex with men (MSM) with HIV are unaware of their HIV infection. In certain circumstances, access to HIV testing and viral load (VL) monitoring is challenging.
Wei Luo   +11 more
doaj   +1 more source

HIV Prevention in Care and Treatment Settings: Baseline Risk Behaviors among HIV Patients in Kenya, Namibia, and Tanzania. [PDF]

open access: yes, 2013
HIV care and treatment settings provide an opportunity to reach people living with HIV/AIDS (PLHIV) with prevention messages and services. Population-based surveys in sub-Saharan Africa have identified HIV risk behaviors among PLHIV, yet data are limited
A Palepu   +52 more
core   +12 more sources

E-Cigarette Use Among Persons With Diagnosed HIV in the U.S.

open access: yesAJPM Focus, 2023
Introduction: E-cigarettes emerged in the U.S. market in the late 2000s. In 2017, E-cigarette use among U.S. adults was 2.8%, with higher use among some population groups.
Stacy L. Thorne, PhD, MPH   +5 more
doaj   +1 more source

Preventing HIV infection [PDF]

open access: yesBMJ, 2005
In 2002 the prevailing view was that preventive strategies rather than the provision of highly active antiretroviral therapy (HAART) were the only feasible way to control the spread of HIV infection. Antiretroviral treatment is now cheaper thanks to initiatives from the pharmaceutical industry and generic manufacture and its wider availability ...
Rachael, Jones   +2 more
openaire   +2 more sources

Pharmacokinetics and efficacy of topical inserts containing tenofovir alafenamide fumarate and elvitegravir administered rectally in macaquesResearch in context

open access: yesEBioMedicine, 2022
Summary: Background: Topical on-demand forms for HIV pre-exposure prophylaxis (PrEP) may be a desirable alternative for people that prefer not to use daily PrEP.
Natalia Makarova   +13 more
doaj   +1 more source

HIV prevention [PDF]

open access: yesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2013
The response to the HIV epidemic has made remarkable advances in the past decade with expansion of access to HIV care and treatment for populations that had hitherto no hope of such treatment.1 At the same time, it is heartening to note that after many years of limited progress, the field of HIV prevention has been greatly energized by several recent ...
Marie-Louise Newell, Frank Tanser
  +4 more sources

The time has come to make cervical cancer prevention an essential part of comprehensive sexual and reproductive health services for HIV-positive women in low-income countries. [PDF]

open access: yes, 2015
IntroductionHIV and cervical cancer are intersecting epidemics that disproportionately affect one of the most vulnerable populations in the world: women in low- and middle-income countries (LMICs).
Cohen, Craig R   +3 more
core   +5 more sources

Home - About - Disclaimer - Privacy